Top news from ENDO: hair care EDCs, cell phone-obesity link, AI thyroid diagnosis and more
Click Here to Manage Email Alerts
The Healio and Endocrine Today editors have compiled the most read news from the Endocrine Society annual meeting in June.
Readers were most interested in learning about the effect of chemicals in hair care products on breast cancer cells, cardiometabolic health impact of heavy mobile device use, growth hormone as a treatment for liver disease, possible menstrual cycle disruption with obesity, and accuracy of artificial intelligence screening of thyroid nodules.
Chemicals found in hair products increase viability of breast cancer cells in Black women
Parabens, a class of endocrine-disrupting chemicals widely found in hair and personal care products, promote viability and gene expression of a breast cancer cell line in Black women.
Excessive mobile device use linked to higher BMI, other adverse health outcomes
People who spend more time per day using wireless mobile devices are more likely to have a higher BMI, lower-quality sleep and other adverse health outcomes.
Growth hormone reduces liver fat, inflammation in adults with NAFLD
Adults with overweight or obesity and nonalcoholic fatty liver disease, or NAFLD, had a significant reduction in liver fat and inflammation with daily subcutaneous growth hormone administration.
Obesity suppresses ovarian follicle development in women with regular menstrual cycles
Women with obesity have fewer ovarian follicles that remained static for longer and regressed more slowly compared with those found in women with normal weight.
Artificial intelligence may be used to identify benign thyroid nodules
An ultrasound-based artificial intelligence classifier of thyroid nodules identified benign nodules with sensitivity similar to fine-needle aspiration.
Collapse
Healio coverage
Click Here to Manage Email Alerts